Financial Gravity Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1
Closed -$118 1033
2020
Q1
$118 Sell
1
-2
-67% -$212 ﹤0.01% 861
2019
Q4
$105K Sell
3
-414
-99% -$46.4K 0.07% 303
2019
Q3
$48K Sell
417
-123
-23% -$18.7K 0.04% 298
2019
Q2
$93K Sell
540
-154
-22% -$26.6K 0.08% 240
2019
Q1
$117K Buy
+694
New +$103K 0.09% 187
2018
Q3
$71K Buy
532
+49
+10% +$7.07K 0.07% 259
2018
Q2
$65K Buy
483
+115
+31% +$16.3K 0.06% 268
2018
Q1
$51K Buy
+368
New +$46.3K 0.05% 307

Other funds holding GWPH

Financial Gravity Asset Management's GWPH Position: Q2 2020 in Review

Financial Gravity Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 1 share — an estimated $118 sold.

Financial Gravity Asset Management first reported a position in GWPH in Q1 2018 and held it in 8 quarters. The position peaked at $117K in Q1 2019. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

  • Financial Gravity Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • Financial Gravity Asset Management sold 1 GW Pharmaceuticals Plc American Depositary Shares share in Q2 2020, an estimated $118.
  • Financial Gravity Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 8 quarters.
  • Financial Gravity Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $117K in Q1 2019.
  • 299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on Financial Gravity Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.